Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spectrum Pharmaceuticals
Pharma
Assertio says activist investor's claims are 'without merit'
Answering allegations from activist investor Buxton Helmsley that it misled investors, Assertio called the claims "baseless."
Kevin Dunleavy
Nov 12, 2024 8:00am
Assertio picks up Spectrum and approved drug in $248M-plus deal
Apr 25, 2023 1:49pm
Moderna, Takeda and Everest—Fierce Pharma Asia
Sep 23, 2022 9:25am
FDA oncology nods will be challenging for Spectrum, Oncopeptides
Sep 21, 2022 8:45am
Spectrum's Rolontis has been hit with an FDA complete response
Aug 6, 2021 9:30am
FDA inspection backlog could keep growing as pandemic rages
Dec 22, 2020 3:00am
